Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 4.09B | 3.61B | 3.15B | 4.26B | 3.23B |
Gross Profit | 1.05B | 919.72M | 586.55M | 716.95M | 623.82M |
EBITDA | 324.37M | 320.07M | 165.32M | 234.82M | 251.80M |
Net Income | 138.07M | 62.59M | -35.97M | 15.30M | 58.52M |
Balance Sheet | |||||
Total Assets | 2.56B | 2.41B | 2.24B | 2.83B | 2.51B |
Cash, Cash Equivalents and Short-Term Investments | 262.44M | 309.92M | 168.96M | 229.71M | 147.18M |
Total Debt | 743.79M | 722.62M | 822.00M | 944.87M | 785.45M |
Total Liabilities | 1.56B | 1.49B | 1.35B | 1.82B | 1.56B |
Stockholders Equity | 973.71M | 925.76M | 895.20M | 992.82M | 954.51M |
Cash Flow | |||||
Free Cash Flow | 184.10M | 358.11M | 98.55M | 69.70M | 46.68M |
Operating Cash Flow | 206.16M | 420.35M | 149.60M | 118.34M | 76.11M |
Investing Cash Flow | -82.70M | -49.46M | -20.79M | 18.62M | 20.61M |
Financing Cash Flow | -214.09M | -231.43M | -191.18M | -55.86M | -197.91M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | HK$507.50M | 3.68 | 14.54% | 8.96% | 13.36% | 120.39% | |
70 Outperform | HK$665.26M | 8.00 | 9.47% | 4.30% | -4.58% | -31.73% | |
56 Neutral | HK$23.69B | 3.90 | -1.57% | 6.91% | 0.06% | -64.88% | |
51 Neutral | HK$75.15M | 5.42 | 19.25% | ― | 20.86% | ― | |
42 Neutral | HK$177.33M | ― | ― | -37.59% | -244.66% | ||
42 Neutral | HK$883.51M | ― | 3.85% | ― | ― | ||
41 Neutral | HK$76.58M | ― | -38.40% | ― | -72.73% | -764.81% |
Sinomax Group Limited has announced amendments to the terms of reference for its Nomination Committee, which is part of its Board of Directors. These changes, effective from July 1, 2025, aim to enhance the governance structure by ensuring a diverse and competent board composition. The amendments align with the Corporate Governance Code under the Hong Kong Stock Exchange’s listing rules, emphasizing the importance of independent non-executive directors and gender diversity within the committee.
Sinomax Group Limited, a company incorporated in the Cayman Islands, announced the successful approval of all resolutions at its Annual General Meeting held on May 16, 2025. The resolutions, which were passed unanimously, included the approval of the company’s audited financial statements, the declaration of a final dividend, the re-election of directors, and the re-appointment of PricewaterhouseCoopers as auditors.
Sinomax Group Limited has announced a change in the composition of its nomination committee. Ms. Lam Fei Man, an executive director, has been appointed as a member of the nomination committee, effective from May 16, 2025. This appointment may influence the company’s governance and decision-making processes, potentially impacting its strategic direction and stakeholder relations.
Sinomax Group Limited has announced changes to its board of directors, effective from May 16, 2025. The board comprises a mix of non-executive, executive, and independent non-executive directors, with Mr. Lam Chi Fan serving as the Chairman. The announcement outlines the roles and functions of each director within the company’s four board committees, which include Audit, Corporate Governance, Nomination, and Remuneration Committees. This restructuring of the board is likely aimed at strengthening corporate governance and enhancing strategic oversight within the company.
Sinomax Group Ltd. has announced its annual general meeting to be held on May 16, 2025, where shareholders will consider several key resolutions. These include the approval of the company’s financial statements for 2024, the declaration of a final dividend, the re-election of directors, and the re-appointment of PricewaterhouseCoopers as auditors. Additionally, the meeting will address the authorization of the board to manage the issuance of shares and related securities, which could have implications for the company’s capital structure and market activities.